The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Efficacy analysis of Shuxuetong injection and vinpocetine for patients with posterior circulation ischemia
Author(s): 
Pages: 679-682
Year: Issue:  11
Journal: World Clinical Drugs

Keyword:  Shuxuetong injectionvinpocetine injectionposterior circulation ischemia(PCI);
Abstract: Objective To discuss the effect of Shuxuetong injection and vinpocetine for patients with posterior circulation ischemia(PCI). Methods Eighty six patients with PCI were randomly divided into treatment group and control group. All patients were treated with routine therapy. Treatment group was treated with vinpocetine injection 30 mg plus Shuxuetong injection 6 ml intravenous infusion once a day. According to clinical signs and symptoms, the neurological deficits improvement, the blood flow rate in vertebral artery and the levels of hemorheology index were compared between two groups. Results The obvious effective rate of treatment group(60.47%) was higher than that of control group(39.53%) and the total effective rate of treatment group(86.05%) was higher than that of control group(67.44%). There was significant difference between two groups(P<0.05). After treatment the vertebral artery peak flow(Vp), the mean flow(Vm) and the difference between both sides(DVm) were improved significantly(P<0.05). The levels of hemorheology indexes in treatment group were ameliorated significantly(P<0.05). Conclusion Shuxuetong injection plus vinpocetine have good clinical effects on posterior circulation ischemia.
Related Articles
No related articles found